Skip to main content

Nitrazepam

ADVERTISEMENT
Identification
Molecular formula
C15H11N3O3
CAS number
146-22-5
IUPAC name
N-methyl-7-nitro-2-oxo-5-phenyl-3H-1,4-benzodiazepine-1-carboxamide
State
State

At room temperature, nitrazepam is in a solid state. It is typically handled in powder form.

Melting point (Celsius)
227.50
Melting point (Kelvin)
500.60
Boiling point (Celsius)
0.00
Boiling point (Kelvin)
0.00
General information
Molecular weight
281.27g/mol
Molar mass
281.2680g/mol
Density
1.4280g/cm3
Appearence

Nitrazepam appears as a white or faintly yellow crystalline powder. It is typically odorless and stable under normal conditions of use and storage.

Comment on solubility

Solubility of N-methyl-7-nitro-2-oxo-5-phenyl-3H-1,4-benzodiazepine-1-carboxamide

The solubility of N-methyl-7-nitro-2-oxo-5-phenyl-3H-1,4-benzodiazepine-1-carboxamide is a topic of interest due to several factors affecting its behavior in various solvents.

Key points regarding its solubility include:

  • Polarity: The presence of both polar and non-polar functional groups in the structure can lead to solubility in a range of organic solvents.
  • pH Sensitivity: The compound may exhibit variable solubility depending on the pH of the solution, thus it could be more soluble in acidic or basic environments.
  • Temperature Influence: Increased temperature generally improves solubility; therefore, heating the solvent can facilitate dissolution.
  • Hydrophobic Interactions: The phenyl group contributes to hydrophobic characteristics, which may limit solubility in polar solvents like water.

In summary, while the exact solubility value can vary depending on experimental conditions, this benzodiazepine derivative demonstrates moderate solubility in organic solvents, with specific behavior influenced by temperature, pH, and the presence of adjacent functional groups. Understanding these factors is crucial for applications in pharmaceuticals and research.

Interesting facts

Interesting Facts about N-methyl-7-nitro-2-oxo-5-phenyl-3H-1,4-benzodiazepine-1-carboxamide

N-methyl-7-nitro-2-oxo-5-phenyl-3H-1,4-benzodiazepine-1-carboxamide is a fascinating compound within the benzodiazepine family, known for its diverse pharmacological activities. This particular compound has garnered attention due to its unique structural features and potential therapeutic applications.

Key Highlights

  • Pharmacological Properties: Compounds like this one are commonly recognized for their anxiolytic (anxiety-reducing), sedative, and muscle relaxant effects.
  • Combinatorial Chemistry: The compound exemplifies the principles of medicinal chemistry, where small changes in the molecular structure can lead to significant variations in biological activity.
  • Research Implications: Studies have explored its potential in treating various neurological disorders, making it a subject of interest in both clinical and preclinical research.
  • Structure-Activity Relationship (SAR): The intricate design allows scientists to study how modifications to different parts of the molecule influence its efficacy and safety profile.

As a *chemical scientist* or *chemistry student*, you might find the nuances of this compound particularly engaging. For instance, benzodiazepines have a common mechanism of action: they enhance the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABAA receptor, which is crucial for their anxiolytic effects. As the well-known saying in pharmacology goes, "the dose makes the poison," highlighting the importance of understanding the dosage for therapeutic use versus toxicity.

The exploration of this compound not only contributes to our knowledge in pharmacology but also shows how chemical modifications can lead to enhanced treatment options for patients suffering from anxiety disorders and related conditions.

In summary, N-methyl-7-nitro-2-oxo-5-phenyl-3H-1,4-benzodiazepine-1-carboxamide represents an important connection between chemistry and medicine, reflecting both the complexities of drug design and the ongoing efforts to improve therapeutic outcomes in healthcare.

Synonyms
D 58SI
27016-91-7
2,3-Dihydro-N-methyl-7-nitro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-1-carboxamide
D-58si
4IAH4S28J2
1H-1,4-Benzodiazepine-1-carboxamide, 2,3-dihydro-N-methyl-7-nitro-2-oxo-5-phenyl-
DTXSID50181499
RefChem:130461
DTXCID10103990
N-methyl-7-nitro-2-oxo-5-phenyl-3H-1,4-benzodiazepine-1-carboxamide
BRN 0899773
UNII-4IAH4S28J2
CHEMBL305389
Q27259622